Nearly one-third of patients with prostate cancer (PCa) experience biochemical recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant metastasis and mortality in patients with prognostically unfavorable features. These patients are best managed with a tailored treatment str...
AUA and SUO publish guideline regarding early detection of prostate cancer | Hormone treatment for biochemical recurrence following definitive therapy of prostate cancer | World-famous surgical museum reopens following multimillion pound renovationPROSTATE cancer...
After a median follow-up of 31 months, the 3-year biochemical recurrence-free survival, clinical recurrence-free survival, and OS were 55%, 59%, and 92%, respectively. Table 4. Studies Evaluating Aggressive Metastasis-Directed Treatment in Patients With Oligometastatic Prostate Cancer StudyNo. o...
Re: Surgeon Experience is Strongly Associated With Biochemical Recurrence After Radical Prostatectomy for All Preoperative Risk Categories E. A. Klein, F. J. Bianco, A. M. Serio, J. A. Eastham, M. W. Kattan, J. E. Pontes, A. J. Vickers and P. T. Scardino J Urol 2008; 179: 2212...
F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewA systematic literature review of the performance ofFluorine-fluciclovine PET/CT for imaging of men with recurrent prostate cancer was performed.Scientific literature databases (MEDLINE, ScienceDirect and ...
18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewBackground A systematic literature review of the performance of Fluorine-fluciclovine PET/CT for imaging of men with recurrent prostate cancer was performed. Methods Scientific literature databases (...
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomyprostate cancersalvage therapysalvagetherapybiochemical recurrenceBCRradical prostatectomy
Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized CohortFine, Samson W.Al-Ahmadie, Hikmat A.Vertosick, EmilyVickers, Andrew J.Ying-Bei Chen
The Journal of UrologyYuh B, Ruel N, Wilson T. Reduction in early biochemical recurrence intermediate risk patients undergoing robot-assisted extended pelvic lymphadenectomy for prostate cancer. J Urol 2015;193(Suppl): e1042.Yuh B, Ruel N, Wilson T. Reduction in early biochemical recurrence ...
Journal of UrologyLogan J, Fabrizio M, Given R, Riggs S, Lance R. Omission of pelvic lymphadenectomy in low-risk prostate cancer patients is not as- sociated with higher rates of biochemical recurrence at five years. J Urol 2011;185(Suppl):e192-3....